Business Standard

WHO advises doctors against using Gilead's remdesivir for treating Covid-19

The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit to coronavirus patients after a study showed it reduced their recovery time

remdesivir, coronavirus, drugs, covid, pharma
Premium

The antiviral has been used widely to treat Covid and was among the drugs President Donald Trump received when he was diagnosed with the disease in early October

Anna Edney | Bloomberg
The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.

“There is currently no evidence that it improves survival or the need for ventilation,” a panel of WHO-convened experts developing Covid-19 treatment guidelines said in The BMJ medical journal.

The recommendation is a blow to Gilead’s drug, which was one of the first thought to offer a meaningful benefit to coronavirus patients after a study showed it reduced their recovery time. 
 
The antiviral has been used widely to treat Covid and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 20 2020 | 9:27 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com